Newly developed glycogen synthase kinase-3 (GSK-3) inhibitors protect neuronal cells death in amyloid-beta induced cell model and in a transgenic mouse model of Alzheimer’s disease
2013 ◽
Vol 435
(2)
◽
pp. 274-281
◽
2006 ◽
Vol 198
(2)
◽
pp. 576
◽
2018 ◽
Vol 13
(4)
◽
pp. 709
◽